https://scholars.lib.ntu.edu.tw/handle/123456789/617108
標題: | Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study | 作者: | Lee M.S. Ryoo B.-Y. CHIH-HUNG HSU Numata K. Stein S. Verret W. Hack S.P. Spahn J. Liu B. Abdullah H. Wang Y. He A.R. Lee K.-H. Bang Y.-J. Bendell J. Chao Y. Chen J.-S. Chung H.C. Davis S.L. Dev A. Gane E. George B. He A.R. Hochster H. CHIUN HSU Ikeda M. Lee J. Lee M. Mahipal A. Manji G. Morimoto M. Numata K. Pishvaian M. Qin S. Ryan D. Ryoo B.-Y. Sasahira N. Stein S. Strickler J. Tebbutt N. |
公開日期: | 2020 | 出版社: | Lancet Publishing Group | 卷: | 21 | 期: | 6 | 起(迄)頁: | 808-820 | 來源出版物: | The Lancet Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085623309&doi=10.1016%2fS1470-2045%2820%2930156-X&partnerID=40&md5=56b4918b2b07689b38e6b4ca3240d637 https://scholars.lib.ntu.edu.tw/handle/123456789/617108 |
ISSN: | 1470-2045 | DOI: | 10.1016/S1470-2045(20)30156-X |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。